Key takeaways “Bioidentical” means structurally identical to the hormones your body makes. Many bioidentical hormones are FDA-approved (such as estradiol and micronized progesterone), while compounded bioidentical hormone therapy (cBHT) is not. The 2020 National Academies (NASEM) report found insufficient evidence to support the routine clinical utility of cBHT and recommended limiting it to two specific […]
Key takeaways The core sermorelin vs HGH difference is mechanism: sermorelin is a GHRH analog that prompts the pituitary to release the body’s own growth hormone in pulses, while HGH (somatropin) supplies the hormone directly. Regulatory status differs sharply. HGH/somatropin is FDA-approved, but only for specific deficiency and medical conditions, not anti-aging. Distributing HGH for […]
Key takeaways Sermorelin is a synthetic peptide copy of the first 29 amino acids of growth hormone-releasing hormone (GHRH 1-29). It signals the pituitary to release the body’s own growth hormone, so it is not human growth hormone (HGH) itself. A branded sermorelin product, Geref, was once FDA-approved, first as a diagnostic agent (1990) and […]
Key takeaways Human chorionic gonadotropin (hCG) acts as a long-acting analog of luteinizing hormone (LH), signaling testicular Leydig cells to make testosterone — which is why clinicians explore its “benefits for men.” FDA-approved hCG products carry only two male indications: hypogonadotropic hypogonadism due to pituitary deficiency and prepubertal cryptorchidism. General testosterone-boosting, fertility-on-TRT, and TRT-adjunct uses […]
Key takeaways Exogenous testosterone suppresses pituitary LH and FSH, which collapses intratesticular testosterone (ITT) and can impair sperm production and shrink the testes. hCG acts on the same Leydig-cell receptor as LH, so it can sustain ITT during TRT; in one short study, low-dose hCG maintained ITT dose-dependently in healthy men. Combining hCG with TRT […]
Key takeaways In a 2025 systematic review and meta-analysis of 10 RCTs (819 men with functional or secondary hypogonadism), SERM therapy (clomiphene or enclomiphene) raised total testosterone by a pooled mean difference of about +274 ng/dL versus placebo (95% CI 191.87 to 355.66; p<0.01) — a study finding, not a promised result. Across the same […]
Key takeaways There is no FDA-approved enclomiphene dosage for men because enclomiphene is not an FDA-approved drug; compounded enclomiphene has not been evaluated by the FDA for safety, quality, or efficacy. In clinical research, enclomiphene citrate was studied at oral doses of roughly 6.25 mg, 12.5 mg, 25 mg, and 50 mg once daily — […]
Key takeaways Clomiphene citrate (Clomid) is a mixture of two isomers; enclomiphene is the antiestrogenic trans-isomer, while zuclomiphene is the more estrogenic, longer-lasting cis-isomer. Clomid is FDA-approved only for ovulatory dysfunction in women desiring pregnancy; use of clomiphene or enclomiphene in men is off-label. Enclomiphene is not FDA-approved for any use and is dispensed as […]
Key takeaways Wherever you get it, testosterone is a DEA Schedule III controlled substance, so legitimate TRT always requires a diagnosis, a valid prescription, and ongoing lab monitoring — online and in-person providers operate under the same rules. A real diagnosis means symptoms plus two low early-morning testosterone tests (the AUA uses a total testosterone […]
Key takeaways When people search “testosterone before and after,” the honest answer is a range, not a guarantee: in a systematic review of hypogonadal men, libido tended to improve from around 3 weeks, while erections could take up to 6 months and body composition unfolded over many months to years. Magnitude is modest, not dramatic. […]
